Predictors of Survival of DKD Patients in Assiut University Hospital
1 other identifier
observational
129
0 countries
N/A
Brief Summary
In recent years, the global prevalence of diabetes has risen significantly. According to the 9th edition of the International Diabetes Federation Atlas, an estimated 463 million adults were living with diabetes in 2019, representing approximately 9.3% of the population, with an average annual increase of 51%. Diabetes is associated with multiple complications that can significantly impact patient outcomes . In 2019 alone, around 4.2 million deaths were attributed to diabetes and its complications, accounting for approximately 11.3% of all global deaths . In diabetic patients, several factors influence renal survival, including glycemic control, blood pressure management, lifestyle interventions, and pharmacological therapies such as renin-angiotensin-aldosterone system (RAAS) inhibitors, sodium-glucose co-transporter-2 (SGLT2) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists(9). Early detection of kidney dysfunction through biomarkers like estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) plays a pivotal role in improving renal outcomes. This study aims to evaluate the factors affecting Patients survival in diabetic patients, identify early predictors of renal function decline, and assess the effectiveness of current therapeutic strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2025
CompletedFirst Posted
Study publicly available on registry
March 7, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedMarch 7, 2025
March 1, 2025
1 year
March 4, 2025
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of CKD in diabetic patients
pergentage of diabetic patients with stage 4,5 chronic kidney disease
baseline
Study Arms (1)
study group
diapetic patient with diabetic nephropathy stage 4,5
Eligibility Criteria
diabetic patients with chronic kideny disease stage 4,5
You may qualify if:
- ● Patients age \> 18 years old
- Both sex
- diabetic patients with HbA1c level \>6.5( Type 1 and 2)
- Diabetic patients with CKD 4, 5 )
- HD Pt
You may not qualify if:
- ● Chronic kidney diseases stage 1,2, and 3.
- Acute kidney injury.
- Patients with any other causes of CKD autoimmune disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- residant doctor at Assiut university hospital
Study Record Dates
First Submitted
March 4, 2025
First Posted
March 7, 2025
Study Start
May 1, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
March 7, 2025
Record last verified: 2025-03